| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0735-1097(10)80176-7 |
| P698 | PubMed publication ID | 1993780 |
| P2093 | author name string | Seiler C | |
| Hess OM | |||
| Turina M | |||
| Jenni R | |||
| Krayenbuehl HP | |||
| Turina J | |||
| Schoenbeck M | |||
| P2860 | cites work | Long-term medical management of hypertrophic obstructive cardiomyopathy | Q33171846 |
| Therapy of hypertrophic cardiomyopathy: medical or surgical? clinical and pathophysiologic considerations | Q33172076 | ||
| Potentially lethal arrhythmias and their management in hypertrophic cardiomyopathy | Q33172591 | ||
| Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features | Q33173218 | ||
| Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population | Q38606791 | ||
| Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl) | Q39107643 | ||
| Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients | Q39588597 | ||
| Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review | Q39614414 | ||
| The analysis and presentation of surgical results by actuarial methods | Q44030264 | ||
| Current operative treatment of obstructive hypertrophic cardiomyopathy | Q68485142 | ||
| Regional left ventricular asynchrony and impaired global left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil | Q68994096 | ||
| Operation for hypertrophic subaortic stenosis in the aged | Q69415909 | ||
| Echocardiographic findings late after myectomy in hypertrophic obstructive cardiomyopathy | Q69640231 | ||
| Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy | Q69738110 | ||
| Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy | Q69882498 | ||
| Does verapamil improve left ventricular relaxation in patients with myocardial hypertrophy? | Q70009694 | ||
| Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients | Q70666978 | ||
| Symptomatic status and prognosis of patients after operation for hypertrophic obstructive cardiomyopathy: efficacy of ventricular septal myotomy and myectomy | Q71240928 | ||
| Surgical treatment versus medical treatment in hypertrophic obstructive cardiomyopathy | Q71240939 | ||
| Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history | Q72132426 | ||
| Amelioration of Angina Pectoris in Idiopathic Hypertrophic Subaortic Stenosis with Beta-Adrenergic Blockade | Q72332591 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypertrophic cardiomyopathy | Q1364270 |
| P304 | page(s) | 634-642 | |
| P577 | publication date | 1991-03-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study | |
| P478 | volume | 17 |
| Q73218094 | A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment |
| Q40786493 | Aortic/mitral obstruction and coarctation of the aorta. |
| Q33867516 | Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points. |
| Q43796487 | Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy |
| Q40752705 | Current perspectives on sudden cardiac death in hypertrophic cardiomyopathy |
| Q39423044 | Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy |
| Q42554748 | Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathy. |
| Q71076713 | Effects of dual-chamber pacing in hypertrophic cardiomyopathy on left ventricular outflow tract obstruction and on diastolic function |
| Q33545470 | Hypertrophic and restrictive cardiomyopathies in the elderly |
| Q72663923 | Hypertrophic cardiomyopathy |
| Q33148719 | Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration |
| Q33174589 | Left ventricular chamber dilatation in hypertrophic cardiomyopathy: related variables and prognosis in patients with medical and surgical therapy |
| Q34297555 | Long-term Clinical and Echocardiographic Follow-up After Surgical Correction of Hypertrophic Obstructive Cardiomyopathy With Extended Myectomy and Reconstruction of the Subvalvular Mitral Apparatus |
| Q40858805 | Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy. |
| Q33174611 | Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy |
| Q24792735 | Medical therapy versus interventional therapy in hypertropic obstructive cardiomyopathy |
| Q60921259 | Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand |
| Q42391490 | Non-surgical ablation of the ventricular septum for the treatment of hypertrophic cardiomyopathy |
| Q55511376 | Non-surgical ablation of the ventricular septum for the treatment of hypertrophic cardiomyopathy. |
| Q34058221 | Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy |
| Q71589363 | Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy |
| Q33858260 | Pacing in hypertrophic cardiomyopathy |
| Q74648407 | Quantitative assessment of the operative results after extended myectomy and surgical reconstruction of the subvalvular mitral apparatus in hypertrophic obstructive cardiomyopathy using dynamic three-dimensional transesophageal echocardiography |
| Q33173891 | Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy |
| Q73723161 | Septal myectomy in hypertrophic obstructive cardiomyopathy: late results with stress echocardiography |
| Q37621585 | State-of-the-art management of hypertrophic cardiomyopathy in children |
| Q39193381 | Surgery for hypertrophic cardiomyopathy. |
| Q36915921 | Surgery insight: Septal myectomy for obstructive hypertrophic cardiomyopathy--the Mayo Clinic experience |
| Q39473836 | Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results |
| Q68194495 | Surgical versus medical therapy of hypertrophic cardiomyopathy: is the perspective changing? |
| Q77315861 | The role of intraoperative echocardiography in valve surgery |
| Q77220911 | Verapamil therapy in infants with hypertrophic cardiomyopathy |
| Q77166058 | [Therapeutic approaches in symptomatic hypertrophic obstructive cardiomyopathy] |
Search more.